Past - Present - Future

SGS M-Scan Ltd was founded as an independent company in 1979 by Professor Howard R. Morris FRS (Imperial College London) to provide Analytical Services, Consultancy and Training, particularly in chromatography and mass spectrometry, to the pharmaceutical and chemical industries.

In the early 1980's, the company, in association with Prof. Morris pioneered the development of specialist analytical services for the Biotechnology industry. Based on the then new ionisation technique of Fast Atom Bombardment (FAB) performed on high field magnet mass spectrometers, the concept of identifying proteins and their modifications by analysing the masses of peptides produced by specific digestion was christened 'MS MAPPING'. This concept was applied by SGS M-Scan to check the protein structure of recombinant and native protein and glycoprotein products, initially using FAB and subsequently the newer techniques of Electrospray mass spectrometry (ES-MS) and Matrix Assisted Laser Desorption Ionization (MALDI).

Since then, SGS M-Scan has continued to pioneer the use of new techniques and aid in the development and application of sophisticated instrumentation to solve a variety of chemical and biochemical problems. Indeed, the SGS M-Scan laboratories are noted for their early adoption of promising new instruments, for example, the Q-TOF mass spectrometer (a novel geometry conceived by Prof. Morris in the early 1990's as potentially the best MS/MS configuration for high sensitivity resolved analysis).

The SGS M-Scan group currently consists of four laboratories: SGS M-Scan Ltd (UK), SGS M-Scan Inc (USA), founded 1984, SGS M-Scan SA (Switzerland), founded 1992 and SGS M-Scan GmbH (Germany), founded 2006, supported by marketing offices and agents worldwide.

SGS M-Scan is committed to maintain the highest level of quality in its analytical services (GLP/cGMP) and in all other elements vital to secure client confidence. In particular, it will continue its investment in new research in both method development and new analytical strategies and in the application of novel instrumentation as it becomes available and proven to be fit for purpose.